Today: May 29, 2016, 9:15 pm

Global bioinformatics IVD testing market: New market research published
Bioinformatics in IVD Testing - a new market research report on 2014-03-14 17:05:02
This report, Bioinformatics in IVD Testing looks at the various IVD market segments where bionformatics is expected to have the most impact.What developments are driving this trend? What are labs and providers doing to incorporate these products into practice? And how are payors and regulators reacting? Who is partnering with who to deliver a solid combination product? This report delves into these issues and provides an excellent round-up of the current status of bioinformatics in the IVD industry.As part of its coverage, the report provides information on the following developments:- Selected Diagnostic Tests That Incorporate Bioinformatics
- Selected Multiplexed Tissue-Based Cancer Tests
- Selected Histology Analyses Software Tools
- Selected Blood-Based Cancer Biomarker Tests That Use Software Analysis Tools
- Selected Chronic Diseases Tests With Integrated Bioinformatics
- Selected Innovations in Bioinformatic-Based Tests For Psychiatric Disorders
- Selected Systems For Bioinformatics-Based Infectious Disease Testing
- Selected Next Generation Sequencing PlatformsThe report discusses tests and technologies that are currently available and those that are expected to take their place. Generally, current products and technologies establish the standard of care and its value to payers. Many of the assays and techniques presented in the report are expected to replace the standard of care in 2013, but with healthcare systems´ emphasis on cost/benefit analysis for new technologies adoption, the market value and thus penetration capabilities of newer approaches may be limited.The report looks at the bioinformatics-based product offerings and developments of the following companies, among others:- Abbott
- Cannon
- RocheAffymetrix Inc.
- AssureRx Health, Inc.
- Bio-Reference Laboratories, Inc. (BRLI)
- Dako A/S
- Siemens
- Thermo Fisher
- Medtronic Inc.
- PerkinElmer, Inc.
- Prometheus Labs
- Quest

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600

# 492 Words
Related Articles
More From Finance
New Frontier Portfolios Top Morningstar Rankings
Boston, April 14, 2016—New Frontier’s global strategic portfolios topped the Global Balanced Strategic category of the latest [..]
Finding an Excellent Tax Lawyer with the [..]
Sound Advice about Finding an Excellent Attorney When an individual requires legal representation, whether for an IRS tax debt [..]
First Gothenburg Bancshares to acquire Nebanco, Inc.
Denver, CO: March 24, 2016 – First Gothenburg Bancshares, Inc., the holding company for First State Bank, Gothenburg, Nebraska [..]
With Bad Credit It Is Still Possible [..]
What to Expect When Seeking a Bad Credit Home Loan Refinance Okay, so not everyone has great – or even [..]
Credit-Yogi Professionals Describe How to Get Out [..]
Who doesn’t want to save money while getting rid of debt? Most folks would jump at the chance to do [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.